This inventor holds 5 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: University of Michigan. Active years: 2009-2020.
Company Filing History:
Years Active: 2009-2020
Title: Mark J Kiel: Innovator in Cancer Research and Genomic Data Analysis
Introduction
Mark J Kiel is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer research and genomic data analysis. With a total of 5 patents, his work focuses on developing innovative methods and systems that enhance cancer diagnosis and treatment.
Latest Patents
One of his latest patents is titled "Recurrent gene fusions in cutaneous CD30-positive lymphoproliferative disorders." This invention provides kits, compositions, and methods for cancer diagnosis, research, and therapy, particularly focusing on recurrent gene fusions as diagnostic markers for specific lymphoproliferative disorders. Another notable patent is "Systems and methods for electronically mining genomic data." This invention outlines a data analysis method and computer system that electronically mines published articles to discover associations between various diseases and genetic changes. The system organizes and prioritizes these associations, facilitating quicker clinical decision-making based on genome sequencing data.
Career Highlights
Mark J Kiel is affiliated with the University of Michigan, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer treatment and genomic research.
Collaborations
He collaborates with notable colleagues, including Omer Yilmaz and Sean J Morrison, who contribute to his research endeavors.
Conclusion
Mark J Kiel's innovative work in cancer research and genomic data analysis exemplifies the importance of scientific advancements in improving healthcare outcomes. His contributions through patents and collaborations continue to shape the future of medical research.